On June 20, 2019, PDL BioPharma, Inc. appointed Ed Imbrogno as Vice President of Finance and Chief Accounting Officer. Prior to the appointment, Mr. Imbrogno was the Company's Vice President of Finance. Mr. Imbrogno, age 55, brings over 30 years of accounting and financial reporting experience to the role. Before joining the Company in October 2018, Mr. Imbrogno was Senior Director and Corporate Controller for BioDelivery Sciences International, Inc. In addition, at its Annual Meeting of Stockholders held on June 20, 2019, the company's stockholders elected Natasha A. Hernday to the company's Board of Directors for a term of three years.